Publication | Open Access

Phase II Trial of Paclitaxel–Topotecan–Etoposide Followed by Consolidation Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer: CALGB 30002

Calgb 30002MedicineMetronomic TherapyConsolidation ChemoradiotherapyPaclitaxel–topotecan–etoposide FollowedBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerRadiologyHealth Sciences